Cumulative Radiation Dose From CT in Young People Linked to Malignancy Risk
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 28, 2023 -- Cumulative radiation dose to the bone marrow as a result of computed tomography (CT) examinations in individuals aged younger than 22 years is associated with an increased risk for subsequent hematological malignancies, according to a study published online Nov. 9 in Nature Medicine.
Magda Bosch de Basea Gomez, Ph.D., from the Barcelona Institute for Global Health in Spain, and colleagues followed a multinational cohort of 948,174 individuals who underwent CT examinations before age 22 years in nine European countries. On the basis of body part scanned, patient characteristics, time period, and inferred CT technical parameters, radiation doses to the active bone marrow were estimated.
The researchers found an association between cumulative dose and risk for all hematological malignancies, with an excess relative risk of 1.96 (95 percent confidence interval, 1.10 to 3.12) per 100 mGy. For lymphoid and myeloid malignancies, similar estimates were obtained. For every 10,000 children examined today (mean dose, 8 mGy), in the subsequent 12 years, one to two persons are expected to develop a hematological malignancy attributable to radiation exposure.
"The findings highlight the need for raising awareness in the medical community and continued strict application of radiological protection measures in medical settings through justification and optimization of radiological procedures, particularly in pediatric populations," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Tumor-Infiltrating Lymphocyte Abundance Prognostic in Early-Stage TNBC
THURSDAY, April 18, 2024 -- For patients with early-stage triple-negative breast cancer (TNBC) who undergo surgery without chemotherapy, tumor-infiltrating lymphocyte (TIL)...
Microwave Ablation Feasible for T1N0M0 Papillary Thyroid Carcinoma
FRIDAY, April 12, 2024 -- For patients with multifocal papillary thyroid carcinoma (PTC), the rates of progression-free survival (PFS) do not differ between microwave ablation...
HYPORT Noninferior for GU, GI Toxicity in Prostate Cancer
WEDNESDAY, April 10, 2024 -- For patients with prostate cancer, hypofractionated postprostatectomy radiotherapy (HYPORT) is noninferior to conventionally fractionated...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.